miRNA 513a-2: A Potential Drug Target and Biomarker (G574510)

Target Name: MIR513A2

NCBI ID: G574510

miRNA 513a-2: A Potential Drug Target and Biomarker

MicroRNA 513a-2 (miRNA 513a-2) is a non-coding RNA molecule that has been shown to play a role in various biological processes. One of the most significant functions of miRNA 513a-2 is its ability to regulate gene expression, which is critical for the development and progression of many diseases.

The discovery and characterization of miRNA 513a-2 was made by a research team led by Dr. Xuan Zhang at the University of California, San Diego. The team identified miRNA 513a-2 using RNA interference (RNAi) technology, which allows researchers to knockdown the expression of specific genes in cells.

Dr. Zhang and his team found that miRNA 513a-2 was highly expressed in various tissues and cells, including the brain, heart, and pancreas. They also observed that miRNA 513a-2 was able to significantly reduce gene expression levels in these tissues, which is consistent with its known function as a negative regulator of gene expression.

In addition to its role in gene expression, miRNA 513a-2 has also been shown to play a role in the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

The study of miRNA 513a-2 has important implications for the development of new drugs and biomarkers for a variety of diseases. For example, because miRNA 513a-2 has been shown to play a negative role in the development of cancer, it may be a potential target for cancer therapies. Additionally, because miRNA 513a-2 has been shown to regulate insulin secretion from pancreatic beta cells, it may be a potential target for treatments of type 1 diabetes.

In conclusion, miRNA 513a-2 is a promising drug target and biomarker for the development of new treatments for a variety of diseases. Further research is needed to fully understand the functions of miRNA 513a-2 and its potential as a drug.

Protein Name: MicroRNA 513a-2

More Common Targets